Abstract:BackgroundIn the classical pathway of retinoic acid (RA) mediated gene transcription, RA binds to a nuclear hormone receptor dimer composed of retinoic acid receptor (RAR) and retinoid X receptor (RXR), to induce the expression of its downstream target genes. In addition to nuclear receptors, there are other intracellular RA binding proteins such as cellular retinoic acid binding proteins (CRABP1 and CRABP2) and cytochrome P450 (CYP) enzymes, whose contributions to the RA signaling pathway have not been fully understood. The objective of this study was to compare the significance of various RA binding receptors, i.e. CRABP1, CRABP2, CYP and RAR in the RA signaling pathway. In this regard, we developed a mathematical model of the RA pathway, which is one of the few models, if not the only one, that includes all main intracellular RA binding receptors. We then performed a global sensitivity analysis (GSA) to investigate the contribution of the RA receptors to RA-induced mRNA production, when the cells were treated with a wide range of RA levels, from physiological to pharmacological concentrations.ResultsOur results show that CRABP2 and RAR are the most and the least important proteins, respectively, in controlling the model performance at physiological concentrations of RA (1–10 nM). However, at higher concentrations of RA, CYP and RAR are the most sensitive parameters of the system. Furthermore, we found that depending on the concentrations of all RA binding proteins, the rate of metabolism of RA can either change or remain constant following RA therapy. The cellular levels of CRABP1 are more important than that of CRABP2 in controlling RA metabolite formation at pharmacological conditions (RA = 0.1–1 μM). Finally, our results indicate a significant negative correlation between total mRNA production and total RA metabolite formation at pharmacological levels of RA.ConclusionsOur simulations indicate that the significance of the RA binding proteins in the RA pathway of gene expression strongly depends on intracellular concentration of RA. This study not only can explain why various cell types respond to RA therapy differently, but also can potentially help develop pharmacological methods to increase the efficacy of the drug.

Retinoid-dependent in vitro transcription mediated by the RXR/RAR heterodimer.

Structural Basis for Retinoic X Receptor Repression on the Tetramer

Rexinoid Inhibits Nrf2-Mediated Transcription Through Retinoid X Receptor Alpha

Structure basis of bigelovin as a selective RXR agonist with a distinct binding mode.

Liganded retinoic acid X receptor α represses connexin 43 through a potential retinoic acid response element in the promoter region

The retinoid X receptor has a critical role in synthetic rexinoid-induced increase in cellular all- trans -retinoic acid

Constitutive Activation of Retinoic Acid Receptor Β2 Promoter by Orphan Nuclear Receptor TR2

Identification of Retinoic Acid As an Inhibitor of Transcription Factor Nrf2 Through Activation of Retinoic Acid Receptor Alpha

Danthron Functions as a Retinoic X Receptor Antagonist by Stabilizing Tetramers of the Receptor

Comparison of phenotypic and global gene expression changes in Xenopus tropicalis embryos induced by agonists of RAR and RXR.

Distinct Roles of GCN5/PCAF-mediated H3K9ac and CBP/p300-mediated H3K18/27ac in Nuclear Receptor Transactivation.

RXRα Inhibits the NRF2-ARE Signaling Pathway Through a Direct Interaction with the Neh7 Domain of NRF2.

Retinoic Acid Nuclear Receptor Α (rarα), a Major Role in Mediating Retinoids Inhibition of Growth in Human Breast Carcinoma Cells

Tuning RXR Modulators for PGC1α Recruitment

A decade of molecular biology of retinoic acid receptors

Molecular Mechanism for the Potentiation of the Transcriptional Activity of Human Liver Receptor Homolog 1 by Steroid Receptor Coactivator-1

Structural basis for the full and partial agonist activities of retinoid X receptor α ligands with an iso-butoxy and an isopropyl group

SREBP-1c mediates the retinoid-dependent increase in fatty acid synthase promoter activity in HepG2

Molecular Basis of the Interaction Between IGFBP-3 and Retinoid X Receptor: Role in Modulation of RAR-signaling

Identification of influential proteins in the classical retinoic acid signaling pathway

Retinoid X receptor ligands: a patent review (2007 – 2013)